Status:

COMPLETED

Doxycycline PEP for Prevention of Sexually Transmitted Infections Among Kenyan Women Using HIV PrEP

Lead Sponsor:

University of Washington

Collaborating Sponsors:

Kenya Medical Research Institute

Kenya National AIDS & STI Control Programme

Conditions:

HIV Infections

HIV/AIDS

Eligibility:

FEMALE

18-30 years

Phase:

PHASE4

Brief Summary

This is a randomized clinical trial of doxycycline post-exposure prophylaxis (dPEP) to reduce bacterial STIs among Kenyan women taking pre-exposure prophylaxis (PrEP). The overarching goal is to asses...

Detailed Description

This study is an open-label 1:1 randomized clinical trial of doxycyline PEP to reduce bacterial STIs - Neisseria gonorrhoeae, Chlamydia trachomatis, and T. pallidum (syphilis) - among Kenyan women tak...

Eligibility Criteria

Inclusion

  • Willing and able to give written informed consent
  • Age ≥18 years and ≤30 years old
  • Female sex at birth
  • HIV-seronegative at the time of last test within the past month and a current prescription for PrEP according to the national guidelines of Kenya (define PrEP eligibility as: partner of HIV-infected person not on ART or on ART for \<6 months, \>1 partner of unknown status, transactional sex, recent STI, recurrent HIV PEP use, inconsistent condom use, or injection drug use).

Exclusion

  • Pregnant
  • Breastfeeding a child
  • Allergy to tetracycline class
  • Current medications which may impact doxycycline metabolism or that are contraindicated with doxycycline, as per the prescribing information. These include systemic retinoids, barbiturates, carbamazepine, phenytoin, and warfarin.
  • Recent use of prolonged (more than 14 day course) antibiotics in the month prior to enrollment
  • Active, clinically significant medical or psychiatric conditions that would interfere with study participation, at the discretion of the site investigator or designee.

Key Trial Info

Start Date :

February 5 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 30 2022

Estimated Enrollment :

449 Patients enrolled

Trial Details

Trial ID

NCT04050540

Start Date

February 5 2020

End Date

October 30 2022

Last Update

July 10 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kenya Medical Research Institute

Kisumu, Kenya